AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% FDC 3.33 ▼-1.19% KOA 3.10 ▲1.64%

HPC The Hydration Pharmaceuticals Company Limited

Consumer Defensive · Food Distribution · website
$0.00
52wk 0.00 – 0.02
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About The Hydration Pharmaceuticals Company Limited

The Hydration Pharmaceuticals Company Limited, together with its subsidiaries, markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, Canada, and the United States. It sells its products under the Hydralyte brand through retail stores and online. The company was founded in 2001 and is based in Melbourne, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$2.15M
P/E (trailing)
P/E (forward)
EPS (trailing)
-0.01
Dividend yield
Payout ratio
0.0%
Beta
0.97
EV / EBITDA
Price / Book
0.93
ROE
-132.2%
Operating margin
-156.5%
Net margin
-115.7%
Total cash
$1.12M
Total debt
$0
Current ratio
2.83
Debt / Equity
Free cash flow
$-2.71M
Avg volume
518,300
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$2.47M
  • Gross profit$1.36M
  • Operating income-$3.15M
  • Net income-$2.86M
  • Diluted EPS-0.01
  • Free cash flow-$3.65M
  • Net debt-$1.12M
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
COL $32.60B 31.9
EDV $6.32B 16.8
A2M $4.98B 26.4
MTS $3.40B 12.4
BGA $1.88B 204.7
CBO $1.57B 32.8
GNC $1.26B
ELD $1.21B 22.6